Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius Sells 215 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 215 shares of the stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $549.06, for a total value of $118,047.90. Following the completion of the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at approximately $970,738.08. This represents a 10.84% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Friday, June 6th, Mark Brosius sold 216 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.11, for a total value of $121,631.76.
• On Wednesday, June 4th, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $552.07, for a total transaction of $118,695.05.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.81, for a total value of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $563.00, for a total value of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total transaction of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $0.98 on Friday, hitting $557.08. 1,103,774 shares of the company's stock were exchanged, compared to its average volume of 1,643,591. The company has a 50-day simple moving average of $521.99 and a 200-day simple moving average of $539.16. The stock has a market capitalization of $199.67 billion, a PE ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $413.52 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the company earned $1.50 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Truist Financial lowered their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Robert W. Baird lowered their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday. Finally, Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Atala Financial Inc purchased a new stake in Intuitive Surgical in the 4th quarter worth $25,000. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the 4th quarter valued at about $26,000. Global Financial Private Client LLC grew its holdings in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Finally, Elite Financial Inc. bought a new position in Intuitive Surgical in the 1st quarter worth about $26,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.